Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2020 Oct-Dec;34(4):299–305. doi: 10.1097/WAD.0000000000000389

Table 1.

Characteristics of study participants (N=275)

Variable Mean (SD) or N (percent)
Age at baseline 86.1 (5.8)
Age at death 91.3 (6.0)
Education 15.1 (2.9)
Female 199 (72.4%)
Non-Hispanic whites 267 (97.1%)
Total literacy at baseline 63.7 (13.7)
Total literacy proximate to death 57.2 (17.3)
Global cognition at baseline 0.04 (0.50)
Global cognition proximate to death −0.68 (0.99)
MMSE at baseline 27.8 (1.9)
MMSE proximate to death 22.6 (7.9)
Alzheimer’s dementia at death 90 (33.1%)
Pathologic AD (NIA Reagan) 156 (61.9%)
Macroscopic infarcts 93 (37.2%)
Microinfarcts 94 (37.6%)
Lewy bodies 60 (23.8%)
LATE-NC
 1 48 (19.3%)
 2 25 (10.0%)
 3 59 (23.7%)
Hippocampal sclerosis 18 (7.4%)
Cerebral amyloid angiopathy
 None 61 (24.3%)
 Mild 100 (39.8%)
 Moderate 54 (21.5%)
 Severe 36 (14.3%)
Atherosclerosis
 None 78 (29.9%)
 Mild 140 (53.6%)
 Moderate 42 (16.1%)
 Severe 1 (0.4%)
Arteriolosclerosis
 None 101 (40.2%)
 Mild 94 (37.5%)
 Moderate 45 (17.9%)
 Severe 11 (4.4%)
*

LATE-NC stage: 1=TDP-43 localized in amygdala only; 2=extension to other limbic regions; 3=extension to neocortical regions